Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 13 Breast 8 Gastrointestinal 6 Other 5 Gynecologic 5 Sarcoma 2 Plasma cell 2 Other hematologic neoplasm 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 263 Radiotherapy 166 Cetuximab 159 Docetaxel 105 Fluorouracil 104 pembrolizumab 94 Radiotherapy, Intensity-Modulated 83 Carboplatin 80 Paclitaxel 73 Nivolumab 59 Erlotinib Hydrochloride 35 Surveys and Questionnaires 32 Gemcitabine 32 durvalumab 30 Radiation 29 Drug Therapy 25 Immunohistochemistry 21 Gefitinib 21 Capecitabine 21 tremelimumab 18 Bevacizumab 18 Surgical Procedures, Operative 17 Sorafenib 17 Magnetic Resonance Spectroscopy 17 Ipilimumab 17 Pemetrexed 16 lenvatinib 15 atezolizumab 15 Radiosurgery 15 Gene Expression Profiling 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Diet Therapy × Head & Neck × Clear all

NCT02869399 2023-03-13

DietINT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡